Home-based exercise program for liver transplant recipients
Official title: A Home-based Exercise and Physical Activity Intervention After Liver Transplantation: Impact of Exercise Intensity - a Monocenter Randomized Controlled Trial [PHOENIX-Liver]
Run by Universitaire Ziekenhuizen KU Leuven · NCT06302205 · Data updated 2026-11-12
This study is testing whether different levels of exercise at home can help people who have recently had a liver transplant feel better and improve their health over six months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 147 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Status | Recruiting |
| Started | March 1, 2023 |
| Main results expected | January 2026 |
| Study ends | December 2026 |
| Registry record updated | April 1, 2024 |
| Trial ID | NCT06302205 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are de novo adult liver transplant recipients who are two to three months post-transplant and have access to a home freezer.
✕Probably not a fit
Patients with severe comorbidities, ongoing malignancies, or those unable to participate in physical exercise due to medical contraindications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of different exercise intensities on the rehabilitation of patients who have recently undergone liver transplantation. Participants will be randomly assigned to one of three training groups (low, moderate, or moderate to high intensity) and will engage in a six-month home-based rehabilitation program supervised by a PHOENIX investigator. Assessments of physical fitness, cardiovascular health, liver function, and body composition will occur at baseline, three months, and six months, alongside monthly questionnaires to evaluate well-being and quality of life. The study aims to establish a feasible and effective exercise regimen to improve long-term outcomes for liver transplant recipients.
Why it matters
Potential benefit: If successful, this program could significantly enhance physical fitness and reduce cardiovascular risks in liver transplant recipients.
How similar studies have gone: Previous studies have shown positive outcomes with structured rehabilitation programs for transplant recipients, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * de novo adult liver transplant recipients with a transplant vintage of two to three months * access to a home freezer (± -18°C) Exclusion Criteria: * Aberrant CPET (abnormal low cardiorespiratory fitness is not considered an exclusion criteria), unstable angina, life-threatening arrhythmias, uncontrolled hypertension/diabetes, HbA1c ≥ 9%, severe pulmonary disease (FEV1 \< 50%), musculoskeletal disorders not allowing physical training on a cycle ergometer, or any other medical reasons by the physician considered to be a contraindication for moderate or high-intensity physical exercise * multi-organ transplantation (exception: combined liver-kidney transplant is considered eligible for participation) * ongoing treatment for malignancies * unable to understand Dutch * no access to smartphone and/or computer with internet access * does not willing to except the general conditions of Coachbox. Preparticipation medical screening (cardiopulmonary exercise testing with 12-lead ECG + stratification of cardiovascular risk factors) will be performed by a cardiologist (Dr. Kaatje Goetschalckx at UZ Leuven).
Where it's running
-
UZ Leuven
Leuven, Vlaams-Brabant, Belgium Recruiting
Study contacts
- Study coordinator: Diethard Monbaliu, MD PhD
- Email: diethard.monbaliu@uzleuven.be
- Phone: +3216342361
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Everolimus-based calcineurin-free immunosuppression one year after liver transplant
This trial tests whether switching to or using everolimus with reduced calcineurin inhibitors after year one post-liver transplant can protect kidney function while maintaining graft health in adults at low rejection risk.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
-
Preoperative CIMT and Intraoperative Hemodynamics in Liver Transplant
This study looks at whether a higher carotid IMT measured before surgery is linked to more unstable blood pressure during liver transplant.
-
Reference framework for outcomes after machine-preserved liver transplantation in Europe
This study tests how liver transplants that use machine perfusion perform in real-world practice, to see how different perfusion methods relate to outcomes for adults in Europe.
-
Even protein distribution plus exercise for people awaiting liver transplant
This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.
-
Xuong tan lac than exercise for joint mobility and muscle endurance
This project will test whether practicing the traditional Xuong tan lac than exercise daily for 12 weeks helps improve joint range of motion and muscle endurance in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.